ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
10/01/2025
Back to search
Official data from USPTO
MERIDIAN CLINICAL RESEARCH
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
MERIDIAN CLINICAL RESEARCH
ST13
US500000077956298Class
42
Filing
77956298
Registration
3983324
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
30
Latest update
10/02/2025
Trademark type
Word
Nice classes
42
Filing date
03/11/2010
Registration date
06/28/2011
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
10/21/2021
Last transaction
10/02/2025
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
First use anywhere
07/15/1999
First use in commerce
07/15/1999
Drawing code
4
Owner type
16
Owner location
Omaha, NE
Examiner
PEREZ,STEVEN M
Law office
L10
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
Meridian Clinical Research, LLC
Representatives
M. Thomas Langan II Dvorak Law Group, LLC
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Medical testing and research servicesconducting clinical trials and surveillance studies of pharmaceuticals and medical devices for the health care industry
Publications
History of USPTO decisions and trademark events.
30 publications found
NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
10/21/2021
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
10/21/2021
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
10/21/2021
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
10/21/2021
E89R
TEAS SECTION 8 & 9 RECEIVED
06/09/2021
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
06/28/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
02/04/2020
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
02/04/2020
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
10/28/2016
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
10/28/2016
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
10/28/2016
E815
TEAS SECTION 8 & 15 RECEIVED
08/23/2016
WOAG
WITHDRAWAL OF ATTORNEY GRANTED
07/07/2016
WOAR
TEAS WITHDRAWAL OF ATTORNEY RECEIVED
07/07/2016
R.PR
REGISTERED-PRINCIPAL REGISTER
06/28/2011
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/12/2011
PUBO
PUBLISHED FOR OPPOSITION
04/12/2011
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
03/04/2011
ALIE
ASSIGNED TO LIE
03/04/2011
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/04/2011
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/15/2010
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/15/2010
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/15/2010
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
06/23/2010
GNRT
NON-FINAL ACTION E-MAILED
06/23/2010
CNRT
NON-FINAL ACTION WRITTEN
06/23/2010
DOCK
ASSIGNED TO EXAMINER
06/15/2010
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/16/2010
NWAP
NEW APPLICATION ENTERED
03/15/2010
Continuous trademark protection
Get notified about every new filing that threatens MERIDIAN CLINICAL RESEARCH or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.